Philip A. Clayton

Recent Peritonitis Associates with Mortality among Patients Treated with Peritoneal Dialysis

Neil Boudville, Anna Kemp, Philip A. Clayton et al. · Journal of the American Society of Nephrology · 2012 · 267 citations · Full text

Dialysis, Renal Pathology, Dialysis Therapy +16

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Death after Kidney Transplantation: An Analysis by Era and Time Post-Transplant

Tracey Ying, Bree Shi, Patrick J. Kelly et al. · Journal of the American Society of Nephrology · 2020 · 182 citations · Full text

Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes

Penelope J. Allen, Steven J. Chadban, Jonathan C. Craig et al. · Kidney International · 2017 · 176 citations · Full text

Glomerular Disease, Glomerulonephritis, Urology +9